EU External Trade - Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, Somatotropin, its derivatives and structural analogues

Extra-EU sourcing of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, Somatotropin, its derivatives and structural analogues is highly concentrated. 🇺🇸 United States captures 54.4% of imports (€173.2M), followed by 🇨🇭 Switzerland (34.4%). With an HHI of 4235, this Concentrated market exposes the EU to supply dependency risks.

European exports of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, Somatotropin, its derivatives and structural analogues are concentrated on a few markets. 🇺🇸 United States accounts for 42.1% (€14.1M), ahead of 🇨🇭 Switzerland (40.3%). The top three destinations are 🇺🇸 United States, 🇨🇭 Switzerland, 🇮🇷 Iran.

Within the EU, 🇩🇰 Denmark concentrates 54.3% of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, Somatotropin, its derivatives and structural analogues imports, well ahead of 🇩🇪 Germany (41.5%). The top importing member states are 🇩🇰 Denmark, 🇩🇪 Germany, 🇸🇪 Sweden.

In 2025, trade flows diverged: imports were rising (3.8%) while exports were falling sharply (-60.2%), signalling a structural market shift.